Optimizing Liver Disease Treatment: The Latest Advances and Guidelines

This comprehensive conference program delves into the latest medications and therapies in liver treatment and transplantation, featuring expert insights from renowned specialists in the field.

Review of Trials and Real-World Data

Get in-depth analysis of the results from trials and real-world data on oral drugs for treating:

• Chronic viral hepatitis B and C
• Non-alcoholic fatty liver diseases (NAFLD)
• Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)
• Hepatocellular carcinoma (HCC) and complications of end-stage liver disease, including thrombocytopenia

Educational Objectives

After attending this conference, participants will be able to:

• Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis, and reproductive health, and chronic liver disease
• Review vascular disorders and coagulation management principles for patients with chronic liver disease
• Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL)
• Evaluate drugs in development for PBC and PSC
• Employ strategies for treating and managing ascites and hepatorenal syndrome
• Describe advances in HCC therapy and management of acute-on-chronic liver disease

Target Audience

This conference is designed for:

• Hepatologists
• Gastroenterologists
• Infectious Disease Specialists

Conference Topics

Explore the latest developments in liver disease treatment with our expert speakers:

• ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD
• Acute-on-Chronic Liver Disease – Timothy Morgan, MD
• Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD
• Advances in HCC – Catherine Frenette, MD
• AGA Guidelines for NAFLD – Mazen Noureddin, MD
• Autoimmune Hepatitis – John Vierling, MD
• Debate: Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD
• EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD
• Panel Discussion 1, 2, and 3
• Reproductive Health and Chronic Liver Disease – Norah Terrault, MD
• Update on Management of Ascites and HRS – Florence Wong, MD
• Vascular Disorders and Anticoagulation – Patrick Northup, MD
• Viral Hepatitis B and C – Julio Gutierrez, MD
• When to Refer for Liver Transplantation – Adam Deising, MD
• WILLIAM S. HAUBRICH LECTURE: What’s New in PBC and PSC – Kris Kowdley, MD

Stay updated on the latest advances and guidelines in liver disease treatment and transplantation. Join us for this comprehensive conference program!